top of page
Conferenza stampa

MEDIA & PRESS UPDATES

News: News
DSC_9768.jpg

FIRST CLINICAL TRIAL WITH SUCCESSFUL RESULTS

October 10, 2022

Our first clinical trial of the cleaning and disinfection device from our revolutionary product range was successfully conducted in May leading up to 30% less post-operative pain.

84_Lumendo_edited_edited.jpg

TOP 100 STARTUP IN SWITZERLAND

September 12, 2022

So proud to be recognized again as one of the TOP 100 Startups 2022. Many thanks to everyone of our team, partners and Venturelab believing in us along the way.

Untitled.png

LUMENDO RECEIVES INNOSUISSE CERTIFICATE

September 8, 2022

We have been certified by the Swiss Innovation Agency as "ready for sustainable growth", which is a great achievement.

blue and white globe with blue plastic frame_edited.jpg

EUROSTARS GRANT WON

August 3, 2022

To us at Lumendo, international collaboration is essential for successful innovation. Therefore, receiving a prestigious Eurostars Grant is a great honour - together with our partners TBD Biodiscovery, Studio Mango and VEDS.

ISO Certificate.png

ISO CERTIFICATION ACHIEVED

June 13, 2022

At Lumendo, the highest quality standards are essential to us.

Our quality management system has been successfully audited. We are now official allowed to develop, manufacturer and distribute devices and materials for dental root canal treatments.

Click on the button below to see the complete certificate.

DSC_0190.jpg

3.5 MCHF: OVERSUBSCRIBED!

May 30, 2022

We are proud to announce that our 2.54 MCHF financing round was oversubscribed by 0.94 MCHF, reaching an astounding overall investment of 3.5 MCHF.

DSC_8153.jpg

APPOINTMENT OF NEW MEMBERS TO THE LUMENDO BOARD OF DIRECTORS

February 16, 2022

Welcome to our new board members! We are happy to announce that Simone Übele-Näscher and Andreas Meldau have joined Lumendo in the quest for revolutionary endodontic treatments. Andreas Meldau was elected by the Lumendo board of directors as President of the board.

Lab Experiment

LUMENDO CLOSES 2.54 MCHF SEED FINANCING ROUND

January 7, 2022

We are very happy to announce the closing of our 2.54 MCHF seed financing round.

The financing round was led by Dominik Lysek, PhD, partner at US-based Revere Partners. Co-investors were Zürich Cantonal Bank and Business Angels Switzerland.

Presse release Dongsheng_edited_edited_edited.png

LUMENDO AG RECEIVES A DONGSHENG CUP AWARD

December 28, 2021

Creating new innovative products is our passion. Therefore, winning an award in the category "Most Innovative and Most Creative" of the "Dongsheng Cup" International Entrepreneurship Competition 2021 is all the more an honour for us.

Learn More
Patrick Griss_website2.PNG

NEW FINANCIAL ADVISOR

April 30, 2021

We are happy to welcome three new board advisors. Their expertise in innovation management in the MedTech industry will play a valuable role in guiding our future strategic decisions. We are confident that our advisors will give rise to new and exciting opportunities and help strengthen Lumendo's position in the endodontic market.

Today, we present our new financial advisor Dr. Patrick Griss:

After graduating with an M.Sc. in Microtechnology from EPF Lausanne (Switzerland), as well as a Ph.D. in Microsystem Technology from the KTH Royal Institute of Technology in Stockholm (Sweden), Dr. Patrick Griss is now an Executive Partner of Zühlke Ventures, a venture capital firm investing in medical device companies in Switzerland, Europe, America, and China.

2021-F21-Linkedinpost-Website-IH-1901-02

TECH TOUR FUTURE 21 TOP PRESENTERS

March 26, 2021

Our CEO Andreas Schmocker was selected among the top presenters of Future 21 Tech Tour. Congratulations!

Tech Tour is a collaborative forum that brings together founders, developers, and industry leaders to share the partnerships, inspiration, and solutions needed to promote world-class innovation.

Robert_Frigg_website.PNG

NEW ENTREPREUNARIAL ADVISOR

March 15, 2021

We are happy to welcome three new board advisors. We will present them during the next months. Their expertise in innovation management in the MedTech industry will play a valuable role in guiding our future strategic decisions. We are confident that our advisors will give rise to new and exciting opportunities and help strengthen Lumendo's position on the endodontic market.


Today, we present you Robert Frigg:

As an active medical device developer, Prof. Dr. h.c. mult. Robert Frigg has spent over 35 years in innovation management positions in the MedTech field. After almost 20 years working in different positions at the AO Foundation, including building up the AO Development Institute. From 1997 to 2003, he worked as VP of Innovation and New Concepts at Mathys Medical. From 2004 to 2012, he was worldwide responsible for technology and innovation as CTO at Synthes Inc., which was later sold to J&J for more than 20 billion USD. Since 2013, Robert Frigg setup and since 2019 owns 41medical, a MedTech company developing solutions for the human musculoskeletal system. 

TechTourFinalists.png

TECH TOUR ALPINE FINALIST

January 2021

After a successful virtual pitch session, Lumendo AG is proud and honored to be part of the 13 World Tour Finalist selected by TechTour Alpine.

Closeup of a Petri Dish

NEW GRANT FROM THE SWISS INNOVATION AGENCY

June 1, 2020

Our hand-santizer project "Disigel" is receiving further support from the Swiss Innovation Agency (Innosuisse). Together with the Swiss Federal Laboratories for Materials Science and Technology (EMPA) and the SPIEZ LABORATORY, we will further develop and test the safety and efficacy against Sars-CoV-2.

DSC_9891.jpg

LUMENDO RECEIVES SUPPORT FROM THE GEBERT RÜF STIFTUNG

April 15, 2020

To help fighting the global Covid-19 pandemic, Lumendo received support from the Gebert Rüf Stiftung to develop a revolutionary, long-lasting hand sanitizer "Disigel". Find out  more in the project description and the press release.

schoolvisit-1920w_edited.jpg

SHAPING THE PROFESSIONALS OF TOMORROW

10 September 2019

A school class from the Liceo Artistico Zurich visited our R&D department and labs. The pupils learned about the fascinating world of light-curing materials and could try out our prototypes themselves in the lab.

download.png

BRIDGING THE RESEARCH FUNDS

August 2019

Lumendo CTO and co-founder Mark Bispinghoff is awarded the SNF BRIDGE "Proof of concept" grant for the project “Photopolymerizable, stable hydrogels for medical applications”.

DSC_9768.jpg

LUMENDO IS AWARDED THE 100K FIT GRANT

July 2019

Lumendo is awarded the 100k FIT grant. The "Foundation for Technological Innovation" helps funding innovative projects in the canton of Vaud and provides appropriate financial assistance to startups.

prix-perl-2019-770x513.jpg

LUMENDO WON THE PERL PUBLIC PRIZE

May 2019

Lumendo wins the Public Price at PERL.

download.png

AGEFI SPEAKS ABOUT US

April 2019

Lumendo is in the news: Lumendo is mentioned by AGEFI, Société de l’Agence Economique et Financière S.A. related to the nomination of PERL (Prix Entreprendre Lausanne Région).

hello.jpg

HELLO TOMORROW CHALLENGE IN PARIS

March 2019

Lumendo is among 80 deep-tech startups from around the world that have qualified for the finals of the Hello Tomorrow Challenge in Paris.

Gebert Rüf.png

GEBERT RÜF FOUNDATION FUNDS OUR PRODUCT DEVELOPMENT.

July 2018

We are happy to receive support by the Gebert Rüf Foundation for the development of our endodontic sealer.

bilan.png

INTERVIEW FOR BILAN MAGAZINE

Jun 2018

The biweekly business magazine Bilan features an article describing how Lumendo wants to revolutionize how dentist place root canal fillings.

DSC_0151.jpg

FEATURED IN THE ETH INDUSTRY NEWSLETTER.

February 2018

Lumendo’s story is covered in the ETH Industry Newsletter.

venture kick.png

VENTUREKICK STAGE THREE

October 2017

After winning Venturekick stage 1 and 2, Lumendo convinces the jury another time and wins stage 3.

lab.png

SELECTED AS VENTURE LEADER LIFE SCIENCE 2017

July 2017

Lumendo CEO and co-founder Andreas Schmocker is selected as a Venture Leader Life Science 2017. This enables him to travel to Boston as part of the Swiss National Startup Team to explore the US startup scene and the US dental and medical device market.

Schneider+Ammann+and+Lumigbo+and+Christi

TOP ONE BUSINESS PLAN @VENTURE.CH COMPETITION

June 2017

Lumendo wins the Venture.ch competition in the categorie Top1 Business plan, selected out of 126 entries.

DSC_9768.jpg

ETH PIONEER FELLOWSHIP AWARDED

May 2017

Lumendo CTO and co-founder Mark Bispinghoff is awarded the ETH Pioneer Fellowship to turn his PhD research into a commercial product. ETH Zürich and the ETH Zürich foundation grants financial support and free lab and office space.

Scientist on Tablet

INNOGRANT FUEL OUR PROJECT

December 2016

Lumendo CEO and co-founder Andreas Schmocker is awarded the EPFL Innogrant

bottom of page